Back to Newsroom
Back to Newsroom

RDInvesting Provides Investors with Free In-Depth Equity Reports on ADXS, BCRX, MOD and RNDY

Wednesday, 19 February 2014 08:50 AM

Topic:

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Advaxis, Inc. (NASDAQ: ADXS) shares gained 5.14 percent to close at $5.52 a share Tuesday. The stock traded between $5.40 and $5.99 on volume of 431,655 shares traded. Analysts at Aegis Capital have recently initiated coverage on the company with a "buy" rating and a price target of $18.00. Shares of Advaxis have gained approximately 30.0 percent year-to-date.

Find out more about Advaxis including full access to the free equity report at:       
www.RDInvesting.com/ADXS

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares increased 9.66 percent to close at $10.67 a share Tuesday. The stock traded between $10.08 and $10.77 on volume of 1.29 million shares traded. Analysts at Needham have recently initiated coverage on the company with a "buy" rating and a price target of $14.00. Shares of BioCryst Pharmaceuticals have gained approximately 40.0 percent year-to-date.

Find out more about BioCryst Pharmaceuticals including full access to the free equity report at:     
www.RDInvesting.com/BCRX

Modine Manufacturing Co. (NYSE: MOD) shares declined 0.61 percent to close at $14.60 a share Tuesday. The stock traded between $14.46 and $14.84 on volume of 214,636 shares traded. Analysts at Sidoti have recently initiated coverage on the company with a "neutral" rating and a price target of $16.00. Shares of Modine Manufacturing have gained approximately 13.0 percent year-to-date.

Find out more about Modine Manufacturing including full access to the free equity report at:     
www.RDInvesting.com/MOD

Roundy's Inc. (NYSE: RNDY) shares increased 1.13 percent to close at $7.17 a share Tuesday. The stock traded between $7.08 and $7.34 on volume of 790,544 shares traded. Analysts at BMO Capital have recently initiated coverage on the company with a "market perform" rating and a price target of $7.50. Shares of Roundy's have fallen approximately 27.0 percent year-to-date.

Find out more about Roundy's including full access to the free equity report at:        
www.RDInvesting.com/RNDY

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:              
Research Driven Investing              
[email protected]

Topic:
Back to newsroom
Back to Newsroom
Share by: